Cytokines profile of mice infected by high and low virulences of Indonesian T. evansi isolates

Dyah Haryuningtyas Sawitri, April Hari Wardhana, Heri Wibowo
 DOI  https://doi.org/10.14334/jitv.v22i3.1666

Abstract

Surra in livestock is caused by Trypanosoma evansi, a homoflagella blood protozoa that circulate in extracellular. This disease is widespread in Asia, Africa, South and Central America. According to the immunological aspect, the severity of surra in livestock and mice which infected by trypanosoma is associated with an inflammatory response. On the other hand, the survival time of mice depends on the regulation of Th1 synthesis and proinflammatory cytokines such as IFN-γ and TNF-α. The aim of this study was to observe the responses of proinflammatory cytokines IFN γ, TNF-α and anti-inflammatory IL-10 which result from interaction with parasites. This information is needed for improvements in the management of prevention of Surra in animals. A total of 30 mice were divided into 3 groups. The group was infected with a low virulency T. evansi (Pml287); high virulence (Bang87) respectively and one group was not infected as control. Mice sera were collected in every 4 days for cytokine measurement using an Enzyme Link-Immunosorbent Assay (ELISA). The result showed a difference response of proinflammatory and antiinflammation cytokine profile between the infected mice by isolates Bang 87 and Pml 287. Early deaths in mice infected by Bang 87 isolate were suspected as a result of the response of systemic inflammation syndromes characterized by elevated IFN-γ levels that were not adequately compensated by anti-inflammatory. Anemia contributes to the cause of death in mice that support multiple organ failures (multiple organ disfunction).

Keywords

Surra; Trypanosoma evansi; Cytokine; IFN γ; TNF-α; IL-10

Full Text:

PDF

References

Abbas A, Litchman A. 2009. Basic immunology. Philadelphia (USA): Saunders, Elsevier.

Adamu S, Ibrahim NDG, Nok AJ, Esievo KAN. 2008. Sialyltransferase activity probably counteracts that of sialidase as one of the possible mechanisms of natural recovery or stabilization of erythrocyte mass in trypanosome-infected animals - A perspective. Afr J Biotechnol. 7:4992–5001.

Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell. 124:783–801.

Almeida I, Camargo M, Proc´opio D. 2000. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO Journal. 19:1476–1485.

Almeida I, Gazzinelli R. 2001. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: Structural and functional analyses. J Leukoc Biol. 70:467–477.

Barkhuizen M, Magez S, Atkinson RA, Brombacher F. 2007. Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis. J Infect Dis. 196:1253–1260.

Basset C, Holton J, O'Mahony R, Roitt I. 2003. Innate immunity and pathogen-host interaction. Vaccine. 21:512–513.

Biswas D, Choudhury A, Misra KK. 2001. Histopathology of Trypanosoma (Trypanozoon) evansi infection in Bandicoot Rat.I.Visceral organs. Exp Parasitol. 99:148–159.

Coldewey SM, Rogazzo M, Collino M, Patel NS, Thiemermann C. 2013. Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse. Dis Model Mech. 6:1031-1042.

Coller S, Mansfield J, Paulnock D. 2003. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-γ-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J Immunol. 171:1466–1472.

Darji A, Beschin A, Sileghem M, Heremans H, Brys L, De Baetselier P. 1996. In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect Immun. 64:1937-1943.

Debierre-Grockiego F, Azzouz N, Schmidt J, Dubremetz JF, Geyer H, Geyer R, Weingart R, Schmidt RR, Schwarz RT. 2003. Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of tumor necrosis factor-alpha production in macrophages. J Biol Chem. 278:32978–32993.

Eckersall PD, Gow JW, McComb C, Bradley B, Rodgers J, Murray M, Kennedy PG. 2001. Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice. Parasitol Int. 50:15-26.

Gao W, Wortis HH, Pereira MA. 2002. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int Immunol. 14:299-308

Gazzinelli R, Denkers E. 2006. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol. 6:895–906.

Ghalib HW, Ahmed M, Steven G. 1993. Interleukin 10 Production correlates with pathology in human leishmania donovani infections. J Clin Invest. 92:324–329.

Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. 2008. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 52:818–827.

Guilliams M, Movahedi K, Bosschaerts T, VandenDriessche T, Chuah MK, Hérin M, Acosta-Sanchez A, Ma L, Moser M, Van Ginderachter JA, Brys L, De Baetselier P, Beschin A. 2009. IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J Immunol. 182:1107–1118.

Habila N, Inuwa MH, Aimola IA, Udeh MU, Haruna E. 2011. Mechanisms of Trypanosoma evansi infections. Res Vet Sci. 93:13-17.

Harris TH, Cooney NM, Mansfield JM, Paulnock DM. 2006. Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infect Immun. 74:4530-4537.

Hertz CJ, Filutowicz H. 1998. Resistance to the African trypanosomes is IFN- gamma dependent. J Immunol. 161:6775–6783.

Jelkmann W. 1998. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 18:555–559.

Jittapalapong S, Pinyopanuwat N, Inpankaew T, Sangvaranond A, Phasuk C, Chimnoi W, Kengradomkij C, Kamyingkird K, Sarataphan N, Desquesnes M, Arunvipas P. 2009. Prevalence of Trypanosoma evansi infection causing abortion in dairy cows in Central Thailand. Kasetsart J Nat Sci. 43:53-57.

Kaushik RS, Uzonna JE, Zhang Y, Gordon JR, Tabel H. 2000. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice. Cytokine. 12:1024–1034.

Kitani H, Black SJ, Nakamura Y, Naessens J, Murphy NB, Yokomizo Y, Gibson J, Iraqi F. 2002. Recombinant tumor necrosis factor alpha does not inhibit the growth of African trypanosomes in axenic cultures. Infect Immun. 70:2210-2214.

Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. 2002. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care. 8:376–388.

Larroche C, Mouthon L. 2004. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 3:69-75.

Mabbott NA, Coulson PS, Smythies LE, Wilson RA, Sternberg JM. 1998. African trypanosomose infections in mice that lack the interferon-c receptor gene: nitric oxide-dependent and independent suppression of T-cell proliferative responses and the development of anaemia. Immunol. 94:476–480.

Magez S, Radwanska M, Drennan M, Fick L, Baral TN, Brombacher F, De Baetselier P. 2006. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 infections. J Infect Dis. 193:1575–1583.

Magez S, Stijlemans B, Caljon G, Eugster HP, De Baetselier P. 1993. Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol. 15:635–641.

Magez S, Truyens C, Merimi M, Radwanska M, Stijlemans B, Brouckaert P, Brombacher F, Pays E, De Baetselier P., 2004. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J Infect Dis. 189:527-539.

Magez S, Radwanska M, Drennan M, Fick L, Baral TN, Allie N, Jacobs M, Nedospasov S, Brombacher F, Ryffel B, De Baetselier P. 2007. Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. J Infect Dis. 196:954-962.

Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P. 1999. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections Infections. Infect Immun. 67:3128–3132.

Magez S, Geuskens M, Beschin A. 1997. Specific uptake of tumor necrosis factor-α is involved in growth control of Trypanosoma brucei. J Cell Biol. 137:715–727.

Maina N, Ngotho JM, Were T, Thuita JK, Mwangangi DM, Kagira JM, Ndung'u JM, Sternberg J. 2004. Proinflammatory cytokine expression in the early phase of Trypanosoma brucei rhodesiense infection in vervet monkeys (Cercopithecus aethiops). Infect Immun. 72:3063-3065.

Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol. 26:1553-1559.

Medzhitov R, Janeway CJ. 2000. Innate immunity. N Engl J Med. 343:338–344.

Mekata H, Konnai S, Mingala CN, Abes NS, Gutierrez CA, Dargantes AP, Witola WH, Inoue N, Onuma M, Murata S, Ohashi K. 2013. Isolation, cloning, and pathologic analysis of Trypanosoma evansi field isolates. Parasitol Res. 112:1513–1521.

Müller U, Köhler G, Mossmann H, Schaub GA, Alber G, Di Santo JP, Brombacher F, Hölscher C. 2001. IL-12-independent IFN-g production by T cells in experimental Chagas’ disease is mediated by IL-18. J Immunol. 167:3346–3353.

Murray RK, Granner DK, Mayes PA, Rodwell. 2003. Harper’s illustrated biochemistry. 26th ed. USA: Appleton & Lange.

Naessens J, Kitani H, Momotani E, Sekikawa K, Nthalea JM, Iraqi F. 2004. Susceptibility of TNF-α-deficient mice to Trypanosoma congolense is not due to a defective antibody response. Acta Trop. 92:193–203.

Naessens J, Kitani H, Nakamura Y. 2005. TNF- a mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin Exp Immunol. 139:405–410.

Namangala B, De Baetselier P, Noël W, Brys L, Beschin A. 2001a. Alternative versus classical macrophage activation during experimental African trypanosomosis. J Leuko Biol. 69:387–396.

Namangala B, Noël W, De Baetselier P, Brys L, Beschin A. 2001b. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis. 183:1794-1800.

Namangala B, Baetselier PD, Beschin A. 2009. Both type- I and type-II responses contribute to murine trypanotoler- ance. J Vet Med Sci. 71:313–318.

Noël W, Hassanzadeh G, Raes G, Namangala B, Daems I, Brys L, Brombacher F, Baetselier PD, Beschin A. 2002. Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect Immun. 70:6180–6187.

Paulnock DM, Coller SP. 2001. Analysis of macrophage activation in African trypanosomiasis. J Leukoc Biol. 69:685-690.

Payne RC, Sukanto IP, Partoutomo S, Jones TW. 1994. Efficacy of cymelarsan treatment of suramin resistant Trypanosoma evansi in cattle. Trop Anim Health Prod 26:92-94.

Payne RC, Sukanto IP, Bazeley K, Jones TW. 1993. The effect of Trypanosoma evansi infection on the oestrous cycle of Friesian Holstein heifers. Vet Parasitol. 51:1–11.

Quan N, Mhlanga JD, Whiteside MB, McCoy AN, Kristensson K, Herkenham M. 1999. Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei. J Comp Neurol. 414:114-130.

Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min HY, Lin L. 1992. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol. 148:808–814.

Reed S, Pihl D, Grabstein KH. 1989. Immune deficiency chronic Trypanosoma cruzi infection recombinant IL-1 restores Th function for antibody production. J Immunol. 142:2067-2071.

Saraiva M, O’Garra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 10:170–181.

Sawitri DH, Wardhana AH, Dewi DA, Ekawasti F, Widjaja E. 2016. Application of dried blood sample on whatman filter paper for detection of Trypanosoma evansi from cattle in Central Kalimantan by Internal Trascriber Spacer-1 Polymerase Chain Reaction. Yulistiani D, Wardhana AH, Inounu I, Bahri S, Iskandar S, Wina E, Ginting SP, Tarigan S, Tiesnamurti B, Romjali E, Herawati T, Anggraeny YN, Shanmugavelu S, Aquino DL. Proceeding International Seminar on Livestock Production and Veterinary Technology. Bogor (Indones): Indonesian Center for Animal Research and Development. p. 191-197.

Sher A, Coffman RL. 1992. Regulation of immunity to para- sites by T cells and T cell-derived cytokines. Ann Rev Immunol. 10:385–409.

Shi M, Wei G, Pan W, Tabel H. 2006. Experimental African trypanosomiasis: a subset of pathogenic, IFN-gammaproducing, MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice. J Immunol. 176:1724–1732.

Shi M, Wei G, Pan W, Tabel H. 2005. Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense. Infect Immun. 73:8393–8396.

Shi M, Wei G, Pan W, Tabel H. 2004. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells. J Leuko Biol. 76:399–405.

Shi M, Pan W, Tabel H. 2003. Experimental African trypanosomiasis: IFN-gamma mediates early mortality. Eur J Immunol. 33:108–118.

Shoda L, Kegerreis K, Suarez C. 2001. DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. Infect Immun. 69:2162–2171.

Sileghem M, Darji A, Hamers R, De Baetselier P. 1989. Modulation of IL-1 production and IL-1 release during experimental trypanosome infections. Immunol. 68:137–139.

Sileghem M, Darji A, Instituut PDEB. 1991. In vitro simulation of immunosuppression caused by Trypanosoma brucei. Immunol. 73:246–248.

Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. 1992. Interleukin 10 and interferon g regulation of experimental Trypanosoma cruzi infection. J Exp Med. 175:169-174.

Stijlemans B, Vankrunkelsven A, Caljon G, Bockstal V, Guilliams M, Bosschaerts T, Beschin A, Raes G, Magez S, De Baetselier P. 2010. The central role of macrophages in trypanosomiasis-associated anemia: rationale for therapeutical approaches. Endocr Metab Immune Disord Drug Targets. 10:71-82.

Titus RG, Sherry B, Cerami A. 1991. The involvement of TNF, IL-1 and IL-6 in the immune response to protozoan parasites. Trends Immunol. 12:A13–A16.

Trinchieri G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol. 13:251–276.

Uzonna JE, Kaushik RS, Zhang Y, Gordon JR, Tabel H. 1998. Experimental murine Trypanosoma congolense infections. II. Role of splenic adherent CD3+Thy1.2+ TCR-alpha beta- gamma delta- CD4+8- and CD3+Thy1.2+ TCR-alpha beta- gamma delta- CD4-8- cells in the production of IL-4, IL-10, and IFN-gamma and in trypanosome-elicited immunosuppression J Immunol. 161:6189-6197.

Verdillo JC, Lazaro JV, Abes NS, Mingala CN. 2012. Comparative virulence of three Trypanosoma evansi isolates from water buffaloes in the Philippines. Exp Parasitol. 130:130–134.

Refbacks

  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.



Bookmark and Share